Parame, Erlinda .
HRN: 24-05-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2023
CO-AMOXICLAV 625MG (TAB)
11/13/2023
11/20/2023
PO
625 Mg
BID
TMSAF
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes